Research output per year
Research output per year
Fingerprint
Dive into the research topics where Hyuncheol Chung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis
Park, S., Nam, C. M., Kim, S. G., Mun, J. E., Rha, S. Y. & Chung, H. C., 2021 Feb, In: European Journal of Cancer. 144, p. 49-60 12 p.Research output: Contribution to journal › Review article › peer-review
-
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Chung, H. C., Bang, Y. J., S Fuchs, C., Qin, S. K., Satoh, T., Shitara, K., Tabernero, J., Cutsem, E. V., Alsina, M., Cao, Z. A., Lu, J., Bhagia, P., Shih, C. S. & Janjigian, Y. Y., 2021 Feb, In: Future Oncology. 17, 5, p. 491-501 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea
Lee, J. B., Jung, M., Kim, J. H., Kim, B. H., Kim, Y., Kim, Y. S., Kim, B. C., Kim, J., Moon, S. H., Park, K. U., Park, M., Park, H. J., Sim, S. H., Yoon, H. M., Lee, S. J., Lee, E., Chun, J. Y., Chung, Y. K., Jung, S. Y., Chung, J. & 4 others, , 2021 Apr, In: Cancer Research and Treatment. 53, 2, p. 323-329 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
MAHOGANY: Margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
Catenacci, D. V. T., Rosales, M., Chung, H. C., Yoon, H. H., Shen, L., Moehler, M. & Kang, Y. K., 2021 Apr, In: Future Oncology. 17, 10, p. 1155-1164 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Boku, N., Satoh, T., Ryu, M. H., Chao, Y., Kato, K., Chung, H. C., Chen, J. S., Muro, K., Kang, W. K., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L. Y., Tamura, T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., Minashi, K. & 5 others, , 2021, (Accepted/In press) In: Gastric Cancer.Research output: Contribution to journal › Article › peer-review
Open Access